Effect of hyaluronic acid on proteolytic enzymes and bone remodeling mediators induced by interleukin 1β (IL-1β) and related to cartilage catabolism

Potential role of hyaluronic acid on bone in osteoarthritis matrix metalloproteinases, aggrecanases, and RANKL expression are partially prevented by hyaluronic acid in interleukin 1-stimulated osteoblasts.

Article specification

This clinical trial was published in 2014 in Journal of J Rheumatol. (IF2014: 3.187) by French specialists. The aim of this study was to determine the effect of hyaluronic acid (HA) on proteolytic enzymes and bone remodeling mediators induced by interleukin 1β (IL-1β) and related to cartilage catabolism in murine osteoblasts.

 

Result

In an inflammatory context in murine osteoblasts, HA can inhibit the expression of MMP and ADAMTS. Because HA can counteract the production of these mediators in chondrocytes, its beneficial effect in osteoarthritis may be due to its action on cartilage and subchondral bone.

Tags: France Clinical trial 2014 J Rheumatology

Hayland Center

© 2018 HYLAND.CENTER ALL RIGHTS RESERVED